c-myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression

Cancer Research

Volumn 58, Issue 22, 1998, Pages 5168-5175

  Thompson, M Anne ^a   Rosenthal, Mark A ^a   Ellis, Sarah L ^b   Friend, Annabel J ^b   Zorbas, Michelle I ^b   Whitehead, Robert H ^a   Ramsay, Robert G ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CANCER; DOWN REGULATION; ELECTRON MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE C MYB; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; APOPTOSIS; BUTYRATES; CELL DIFFERENTIATION; COLON; COLONIC NEOPLASMS; DNA FRAGMENTATION; DOWN-REGULATION; ENZYME INDUCTION; GENE AMPLIFICATION; GENES, BCL-2; HUMANS; ONCOGENES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0032534074     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Weston, K. M. The myb genes. Semin. Cancer Biol., 1: 371-382, 1990.
2. Luscher, B., and Eisenman, R. N. New light on Myc and Myb. Part II: Myb. Genes Dev., 4: 2235-2241, 1990.
3. Sheng-Ong, G. L. The myb oncogene. Biochim. Biophys. Acta, 1032: 39-52, 1990.
4. Calabretta, B. Inhibition of proto-oncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications. Cancer Res., 51: 4505-4510, 1991.
5. Mucenski, M. L., McLain, K., Kier, A. B., Swerdlow, S. H., Schreiner, C. M., Miller, T. A., Pietryga, D. W., Scott, W. J. J., and Potter, S. S. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65: 677-689, 1991.
6. Badiani, P., Corbella, P., Kioussis, D., Marvel, J., and Weston, K. Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Dev., 8: 770-782, 1994.
7. Danish, R., el Awar, O., Weber, B. L., Langmore, J., Turka, L. A., Ryan, J. J., and Clarke, M. F. c-myb effects on kinetic events during MEL cell differentiation. Oncogene, 7: 901-907, 1992.
8. Patel, G., Kreider, B., Rovera, G., and Reddy, E. P. v-myb blocks granulocyte colony-stimulating factor-induced myeloid cell differentiation but not proliferation. Mol. Cell. Biol., 13: 2269-2276, 1993.
9. Frampton, J., Ramqvist, T., and Graf, T. v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev., 10: 2720-2731, 1996.
10. Taylor, D., Badianai, P., and Weston, K. A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev., 10: 2732-2744, 1996.
11. Sala, A., Casella, I., Grasso, L., Bellon, T., Reed, J. C., Miyashita, T., and Peschle, C. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53. Cancer Res., 56: 1991-1996, 1996.
12. Salomoni, P., Perrotti, D., Martinez, R., Francheschi, C., and Calabretta, B. Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity. Proc. Natl. Acad. Sci. USA, 94: 3296-3301, 1997.
13. Colony, P. C. The identification of cell types in the normal adult colon. In: L. H. Augenlicht (ed.), Cell and Molecular Biology of Colon Cancer, pp. 139-163. New York: CRC Press, 1989.
14. Augenlicht, L. Adhesion molecules, cellular differentiation and colonic crypt architecture. Gastroenterology, 107: 1894-1898, 1994.
15. Laboisse, C. L. Differentiation of colon cells in culture. In: L. H. Augenlicht (ed.), Cell and Molecular Biology of Colon Cancer, pp. 27-44. New York: CRC Press, 1989.
16. Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. E., and MacFarlane, G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut, 28: 1221-1227, 1987.
17. Augeron, C., and Laboisse, C. L. Emergence of permanently differentiated cell clones in a human colon cancer cell line after treatment with sodium butyrate. Cancer Res., 44: 3961-3969, 1984.
18. Whitehead, R. H., Young, G. P., and Bhathal, P. S. Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut, 27: 1447-1463, 1986.
19. Gamet, L., Daviaud, D., Denis-Pouxviel, C., Remesy, C., and Murat, J. C. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT-29. Int. J. Cancer, 52: 286-289, 1992.
20. Deng, G., Lui, G., Hu, H., Gum, J. R., and Kim, Y. S. Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate. Cancer Res., 52: 3378-3382, 1992.
21. Morita, A., Tsao, D., and Kim, Y. S. Effect of sodium butyrate on alkaline phosphatase in HRT-18, a human rectal cancer cell line. Cancer Res., 42: 4540-4546, 1982.
22. Tsao, D., Morita, A., Bella, A., Luu, P., and Kim, Y. S. Differential effects of sodium butyrate, dimethyl sulfoxide, and retanoic acid on membrane-associated antigens, enzymes and glycoproteins of human rectal adenocarcinoma cells. Cancer Res., 42: 1052-1056, 1982.
23. Chung, Y. S., Song, I. S., Erikson, R. H., Sleisenger, M. H., and Kim, Y. S. Effect of growth and sodim butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res., 45: 2976-2982, 1985.
24. Herz, F., and Halwer, M. Differential effects of sodium butyrate and hyperosmolarity on the modulation of alkaline phosphatases of LoVo cells. Exp. Cell Res., 188: 50-54, 1990.
25. Nathan, D. F., Burkhart, S. R., and Morin, M. J. Increased cell surface EGF receptor expression during the butyrate-induced differentiation of human HCT-116 colon tumour cell clones. Exp. Cell Res., 190: 76-82, 1990.
26. Barnard, J. A., and Warwick, G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ., 4: 495-498, 1993.
27. Mickley, L. A., Bates, S. E., Richert, N. D., Currier, S., Tanaka, S., Foss, F., Rosen, N., and Fojo, A. T. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agent. J. Biol. Chem., 264: 18031-18034, 1989.
28. Heerdt, B. G., Houston, M. A., and Augenlicht, L. H. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colon carcinoma cell lines. Cancer Res., 54: 3288-3294, 1994.
29. Hague, A., Elder, D. J. E., Hicks, D. J., and Paraskeva, C. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt, deoxycholate. Int. J. Cancer, 60: 400-406, 1995.
30. Calabresse, C. L., Venturini, L., Ronco, G., Villa, P., Chomienne, C., and Belpomme, D. Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line. Biochem. Biophys. Res. Commun., 195: 31-38, 1993.
31. Filippovich, I., Sorokina, N., Khanna, K. K., and Lavin, M. F. Butyrate induced apoptosis in lymphoid by transient over-expression of Hsp70 mRNA. Biochem. Biophys. Res. Commun., 198: 257-265, 1994.
32. Bedi, A., Pasricha, P. J., Akhtar, J. P., Barber, G. C. Bedi, G. C., Giardiello, F. M., Zehnbauer, B. A., Hamilton, S. R., and Jones, R. J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55: 1811-1816, 1995.
33. Strater, J., Koretz, K., Gunthert, A. R., and Moller, P. In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut, 37: 819-825, 1995.
34. Lu, Q. L., Poulson, R., Wong, L., and Hanby, A. M. Bcl-2 expression in adult and embryonic non-hemopoietic tissues. J. Pathol., 169: 431-437, 1993.
35. Krajewsi, S., Krajewsi, M., and Reed, J. C. Immunohistochemical analysis of in vitro patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res., 56: 2849-2855, 1996.
36. Merritt, A. J., Potten, C. S., Kemp, C. J., Hickman, J. A., Balmain, A., Lane, D. P., and Hall, P. A. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res., 54: 614-617, 1994.
37. Alitalo, K., Vingvist, R., Lin, C. C., de la Chapelle, A., Schwab, M., and Bishop, J. M. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc. Natl. Acad. Sci. USA, 81: 4534-4538, 1984.
38. Torelli, G., Venturelli, D., Colo, A., Zanni, C., Selleri, A., Moretti, L., Calabretta, B., and Torelli, U. Expression of c-myb proto-oncogene and other cell-cycle related genes in normal and neoplastic human colonic mucosa. Cancer Res., 47: 5266-5269, 1987.
39. Trainer, D. L., Kline, T., McCabe, F. L., Faucette, L. F., Field, J., Chaiken, M., Anzano, M., Reiman, D., Hoffstein, S., Li, D-J., Gennaro, D., Buscarino, C., Lynch, M., Poste, G., and Greig, R. Biological characterization and oncogene expression in human colo-rectal carcinoma cell lines. Int. J. Cancer, 41: 287-296, 1988.
40. Ramsay, R. G., Thompson, M. A., Hayman, J. A., Reid, G., Gonda, T. J., and Whitehead, R. H. Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa. Cell Growth Differ., 3: 723-730, 1992.
41. Thompson, M. A., and Ramsay, R. G. Myb: an old oncoprotein with new roles. BioEssays, 17: 341-350, 1995.
42. Melani, C., Rivoltini, L., Parmiani, G., Calabretta, B., and Colombo, M. P. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res., 51: 2897-2901, 1991.
43. Rosenthal, M. A., Thompson, M. A., Ellis, S., Whitehead, R. H., and Ramsay, R. G. Colonic expression of c-myb is initiated in utero and continues throughout adult life. Cell Growth Differ., 7: 961-967, 1996.
44. Thompson, M. A., Flegg, R., Westin, E. H., and Ramsay, R. G. Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines. Oncogene, 14: 1715-1723, 1997.
45. Whitehead, R. H., Jones, J. K., Gabriel, A., and Lukies, R. E. A new colon cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vivo. Cancer Res., 47: 2683-2689, 1987.
46. Whitehead, R. H., Zhang, H. H., and Hayward, I. P. Retention of tissue-specific phenotype in a panel of colon cell lines: relationship to clinical correlates. Immunol. Cell Biol., 70: 227-236, 1992.
47. Sommer, A. J. The determination of acid and alkaline phosphatase using p-nitrophenyl phosphate substrate. Am. J. Med. Technol., 20: 244, 1954.
48. Ishida, Y., Agata, Y., Shibahara, K., and Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J., 11: 3887-3895, 1992.
49. Butt, A. J., Hague, A., and Paraskeva, C. Butyrate-but not TGF-mediated apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatase. Cell Death Differ., 4: 725-732, 1997.
50. Selvakumaran, M., Lin, H. K., Sjin, R. T., Reed, J. C., Liebermann, D. A., and Hoffman, B. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. Mol. Cell. Biol., 14: 2352-2360, 1994.